NTRA
NASDAQ · Biotechnology
Natera Inc
$259.97
+25.21 (+10.74%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+12.40%
1Y
+58.36%
YTD
+13.60%
Open$243.00
Previous Close$234.76
Day High$264.65
Day Low$239.00
52W High$256.36
52W Low$131.81
Volume—
Avg Volume1.26M
Market Cap33.14B
P/E Ratio—
EPS$-1.64
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$229.31
Above
SMA 200
$186.42
Above
RSI (14)
38.6
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
27 analysts
Price Target
-45.0% upside
Current
$259.97
$259.97
Target
$142.91
$142.91
$88.14
$142.91 avg
$188.78
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.42B | 1.71B | 5.13B |
| Net Income | -218,045,428 | -139,039,878 | 875.75M |
| Profit Margin | -9.0% | -8.6% | 17.1% |
| EBITDA | -322,836,128 | -217,297,946 | 1.33B |
| Free Cash Flow | — | — | 778.23M |
| Rev Growth | +41.1% | +41.1% | +14.5% |
| Debt/Equity | 0.05 | 0.05 | 1.21 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.89 | +0.06% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $351.43 | +1.27% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.16 | +0.09% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $475.20 | +1.45% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $623.43 | +0.87% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $294.06 | +2.04% | 64.3 | 37.13B |